Caicedo A, Naulaers G, Lemmers P, van Bel F, Wolf M, Van Huffel S Detection of cerebral autoregulation by near-infrared spectroscopy in neonates: performance analysis of measurement methods. J Biomed Opt. 2012 Nov;17(11):117003. doi: 10.1117/1.JBO.17.11.117003.
Couture A, Veyrac C, Baud C, Saguintaah M, Ferran JL Advanced cranial ultrasound: transfontanellar Doppler imaging in neonates. Eur Radiol. 2001;11(12):2399-410. doi: 10.1007/s00330-001-1150-z. Epub 2001 Oct 30.
de Waal KA, Evans N, Osborn DA, Kluckow M Cardiorespiratory effects of changes in end expiratory pressure in ventilated newborns. Arch Dis Child Fetal Neonatal Ed. 2007 Nov;92(6):F444-8. doi: 10.1136/adc.2006.103929. Epub 2007 Apr 25.
Evans N, Kluckow M, Simmons M, Osborn D Which to measure, systemic or organ blood flow? Middle cerebral artery and superior vena cava flow in very preterm infants. Arch Dis Child Fetal Neonatal Ed. 2002 Nov;87(3):F181-4. doi: 10.1136/fn.87.3.f181.
Hamon I, Hascoet JM, Debbiche A, Vert P Effects of fentanyl administration on general and cerebral haemodynamics in sick newborn infants. Acta Paediatr. 1996 Mar;85(3):361-5. doi: 10.1111/j.1651-2227.1996.tb14033.x.
Ikeda T, Amizuka T, Ito Y, Mikami R, Matsuo K, Kawamura N, Fusagawa S Changes in the perfusion waveform of the internal cerebral vein and intraventricular hemorrhage in the acute management of extremely low-birth-weight infants. Eur J Pediatr. 2015 Mar;174(3):331-8. doi: 10.1007/s00431-014-2396-1. Epub 2014 Aug 30.
Kluckow M, Evans N Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2000 May;82(3):F188-94. doi: 10.1136/fn.82.3.f188.
Kluckow M, Evans N Superior vena cava flow in newborn infants: a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed. 2000 May;82(3):F182-7. doi: 10.1136/fn.82.3.f182.
McGovern M, Miletin J A review of superior vena cava flow measurement in the neonate by functional echocardiography. Acta Paediatr. 2017 Jan;106(1):22-29. doi: 10.1111/apa.13584. Epub 2016 Sep 28.
Osborn DA, Evans N, Kluckow M Hemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics. 2003 Jul;112(1 Pt 1):33-9. doi: 10.1542/peds.112.1.33.
Papile LA, Burstein J, Burstein R, Koffler H Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978 Apr;92(4):529-34. doi: 10.1016/s0022-3476(78)80282-0.
Pfannschmidt J, Jorch G Transfontanelle pulsed Doppler measurement of blood flow velocity in the internal jugular vein, straight sinus, and internal cerebral vein in preterm and term neonates. Ultrasound Med Biol. 1989;15(1):9-12. doi: 10.1016/0301-5629(89)90126-9.
van Bel F, Mintzer JP Monitoring cerebral oxygenation of the immature brain: a neuroprotective strategy? Pediatr Res. 2018 Aug;84(2):159-164. doi: 10.1038/s41390-018-0026-8. Epub 2018 Aug 16. Erratum In: Pediatr Res. 2018 Aug 6;:
Woolfall K, Frith L, Gamble C, Gilbert R, Mok Q, Young B; CONNECT advisory group How parents and practitioners experience research without prior consent (deferred consent) for emergency research involving children with life threatening conditions: a mixed method study. BMJ Open. 2015 Sep 18;5(9):e008522. doi: 10.1136/bmjopen-2015-008522.
Woolfall K, Frith L, Gamble C, Young B How experience makes a difference: practitioners' views on the use of deferred consent in paediatric and neonatal emergency care trials. BMC Med Ethics. 2013 Nov 6;14:45. doi: 10.1186/1472-6939-14-45.
Sonographic Quantification of Venous Circulation in the Preterm Brain
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
